Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

GREY:TBPMQ - Post Discussion

Tetra Bio Pharma Inc > 1st milstone achieved more to come πŸ’ŠπŸ‘€πŸ’°πŸš€
View:
Post by Golddetector on Sep 02, 2021 8:20am

1st milstone achieved more to come πŸ’ŠπŸ‘€πŸ’°πŸš€

Great news today as QIXLEEF is going global. Big achievement imo. It is a major milestone for tbp. The news speaks for itself. The rest of milestones listed below. All will come one by one.more exciting that Bigger things are ahead of us. Gl longs
Comment by Golddetector on Sep 02, 2021 8:27am
the milestones. See below Short-Term Value-Creating Milestones QIXLEEF - PLENITUDE: Q2: ACCELERATE PATIENT ENROLMENT Q3: RECEIVE OPINION FROM EMA – MALTA COMPETENT AUTHORITY QIXLEEF – REBORN1: Q2: 1ST PATIENT IN Q3: INTERIM ANALYSIS Q3: RECEIVE OPINION FROM EMA – MALTA COMPETENT AUTHORITY Q1-22: END OF ENROLMENT ARDS-003: Q4: LAST HEALTHY VOLUNTEER Q1-22: LAST PATIENT IN CAU ...more  
Comment by Bangada on Sep 02, 2021 1:03pm
Getting feedback is great news, but you equal getting feedback (positive feedback can still mean that the regulators see major major problems and a high degree of unlikelyness for success) to having a product almost ready for sale...which is insane. In reality, we are at the eaxact same position as yesterday, sadly.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities